Stay updated with breaking news from Medication Errors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The availability of these medications is an important first step demonstrating Phlow’s commitment to CHC members to provide a reliable and...
Press release content from Business Wire. The AP news staff was not involved in its creation.
Children’s Hospital Coalition (CHC) encourages more children’s hospitals to join and tackle the shortage crisisRICHMOND, Va.--(BUSINESS WIRE)--Phlow, a U.S.-based, public benefit impact-driven pharmaceutical company, announced the launch of key essential medicines, sequentially over the coming quarter, for the Child...
NEW YORK, January 18, 2022 - Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), is maintained against the SARS-CoV-2 variant Omicron. Taken together, these in vitro studies suggest that PAXLOVID has the potential to maintain plasma concentrations many-fold times higher than the amount required to prevent Omicron from replicating in cells. “We specifically designed PAXLOVID to retain its a...
Caroline McCarthy and colleagues investigate the effect of a general practitioner-delivered, individualized medication review on polypharmacy and potentially inappropriate prescribing in community dwelling older patients with multimorbidity in Irish primary care.